Navigate Pneumococcal Vaccines for Adults

March 2023

Ongoing changes with pneumococcal vaccine recommendations for adults can make your head spin.

Last year, CDC recommended Prevnar 20 (PCV20) or Vaxneuvance (PCV15) over Pneumovax 23 (PPSV23) alone for eligible adults...those 65 and up or 19 to 64 with risk factors (cancer, diabetes, smoking, etc).

Now CDC’s updated immunization schedule clarifies the role of PCV20 to finish an incomplete series...or for adults who’ve had Prevnar 13 (PCV13) plus PPSV23.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote